NCT03067480 - Comparison of 3 Versus 6-Month Use of CGMS in Non-Insulin Using T2DM Patients | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 6, 2017

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions

T2DM (Type 2 Diabetes Mellitus)Continuous Glucose Monitoring

Interventions

DEVICE

iPro2 Professional CGM

Professional CGM measures interstitial glucose every 5 minutes via a glucose-oxidase-impregnated membrane during a 3 day period. The patient wearing professional CGM is blinded to the repeated measurements and the data is stored for retrospective analysis.

Trial Locations (1)

37614

East Tennessee State University, Johnson City